Study Shows Vitamin C Might Be Effective Alternative to Fosamax
A new study suggests large amounts of vitamin C might be beneficial to women in lieu of taking Fosamax to combat the effects of postmenopausal bone loss…. Read more
Fosamax Femur Fracture Lawsuits Information Center
Fosamax, made and sold by pharmaceutical giant Merck & Co., is prescribed for post-menopausal women and men with osteoporosis, Fosamax works by reducing bone degeneration, a process referred to as “resorption.”
Since 2000, the U.S. FDA has known about Fosamax’s tendency to cause osteonecrosis of the jaw (ONJ), a painful, disfiguring bone disease. More recently, research has shown that Fosamax is linked to sudden, unusual bone fractures, particularly in the femur.
You’ve probably heard about no-fee-until-you-win arrangements. It’s simple, and you’ll get it here. Only if and when you recover money to compensate you for your harm will you pay RLG. Otherwise, you pay nothing at all.
If you call for a free initial claim evaluation, you have no obligation whatsoever to hire RLG to represent you. If you do want RLG to stand up for you, we’ll send you an information package with a retainer agreement.
Every legal claim has a time limit. If you don’t sue in time, you risk losing your claim forever. You don’t want to delay. You want to be made whole again. So call RLG now to get the process started.
Unfortunately, when the clock starts—and how long it will run—isn’t always clear before it’s too late. That’s why speaking to a lawyer as soon as possible is the smart thing to do.
Fosamax is the most popular osteoporosis drug on the market, but recent studies have uncovered a defect in the medication.
Given the potential risk of femur fractures, if you’ve suffered a bone break after taking Fosamax, you at least have a claim worth exploring.
No one can say how much you might be owed if you were injured by Fosamax—but you’ll likely get nothing at all if you don’t sue.
Fosamax Updates
Merck Shares Phase II Test Results of New Osteoporosis Drug
Merck, the manufacturer of Fosamax, has revealed the results of phase II testing of its new osteoporosis drug meant to treat post-menopausal women. … Read more
Fosamax Not Necessary for Treatment of Secondary Osteoporosis
A recent Singaporean study has determined that Fosamax might not be an appropriate treatment for osteoporosis brought on by other serious medical conditions…. Read more
As Featured In
“The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes with commingled optimism and circumspection a new report that some troubled drugs, including Fosamax, might aid in the treatment of certain cancers.”
Read the full storyThe Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, is paying especial attention to the developments in the fifth case involving Fosamax and a painful condition known as osteonecrosis of the jaw to go to trial, now underway.
Read the full story